Roxana Mehran News Today

Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, looking exclusively at women.

May is Women’s Health Month, and today we sit down with a medical expert to talk about the under-representation of women in clinical trials. Dr. Roxana Mehran j

The TCT 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientif

The TCT 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientif

Two common devices go head to head in people with small aortic annuli

Standard medications losing appeal amid more modern heart attack treatments

Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities...

WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 10, 2023--

New study includes patients aged ≥65 years with atrial fibrillation (AF) at high risk for ischemic stroke or systemic embolism who are deemed ineligible for oral anticoagulant (OAC) treatment due to increased risk of bleedingOCEANIC-AFINA, the latest Phase III study in the OCEANIC clinical trial program, will invest...

Taken together, a host of neutral or underpowered studies hint at a benefit to personalizing DAPT decisions, a new review argues.